Inactive Instrument
e-therapeutics plc Stock
Stocks
ETPPF
GB00B2823H99
Biotechnology & Medical Research
OTC Markets Traded| 1 day | -7.14% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Director of Finance/CFO | - | 20/09/2023 | |
Alan Whitmore
CTO | Chief Tech/Sci/R&D Officer | - | 01/02/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Trevor Jones
CHM | Chairman | 84 | 01/03/2021 |
| Director/Board Member | 70 | 10/02/2020 | |
David Prior
CHM | Chairman | - | 23/05/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/1/24 | Buy | Director | 91,325 | 0.0156% | ||
| 20/2/23 | Others | Chief Executive Officer | 50,941,666 | 8.7505% | ||
| 20/2/23 | Others | Chief Executive Officer | 50,941,666 | 8.7505% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -7.14% | -37.35% | - | - | 101M | |
| -6.60% | -10.93% | +45.08% | +60.01% | 68.98B | |
| -4.09% | -0.11% | +2.31% | +54.81% | 53.15B | |
| +0.03% | +5.56% | +10.18% | +41.75% | 50.83B | |
| -1.63% | +1.99% | +28.82% | +33.20% | 44.61B | |
| -5.59% | -6.88% | +255.70% | +417.91% | 40.57B | |
| -1.41% | +4.04% | +15.96% | +112.02% | 42.53B | |
| +6.53% | +8.02% | +18.98% | +54.58% | 30.95B | |
| -0.90% | -10.91% | +34.11% | -1.83% | 25.44B | |
| -2.83% | -9.77% | -16.74% | -9.78% | 22.66B | |
| Average | -2.45% | +1.52% | +43.82% | +84.74% | 42.19B | |
| Weighted average by Cap. | -2.51% | +1.65% | +45.20% | +89.00% |
Employees
40
